The abstract is read at the publisher; the summary is JClub's.
In 1180 rheumatology referrals, the triage pathway diagnosed iRMD in 314 patients (32%) and shortened time to final assessment for iRMD cases (33 vs 55 days).
- Why it matters: Rheumatology services need faster identification of inflammatory rheumatic and musculoskeletal disease while avoiding missed cases and unnecessary delays for comprehensive workups.
- What they did: Consecutive referrals underwent a telephone interview (step 1) and a 10-minute rheumatologist consultation within 4 weeks (step 2), then were scheduled for inpatient assessment (step 3); diagnostic performance and wait times were analyzed, with ML models retrospectively evaluated.
- The result: Step 2 sensitivity for iRMD was 67.2% and specificity was 75.4%, with AUC-ROC of 0.73 for step 1 and 0.78 for step 2; ML may improve triage, but one-third of iRMD cases were otherwise missed.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.